KRAS and neoplasm: Finally, the analysis of KRAS with a semi-quantitative method (454-NGS or ASLNAqPCR), performed on material of well-known cellular composition, allows to clarify if mutations (single or multiple) are present in a small percentage of tumor cells (sub-clones) or in the vast majority of them as in the case of all “driver” mutations [33].